Reta glucagon-like peptide-1 (GLP-1) receptor agonists represent a groundbreaking strategy to diabetes management. These innovative drugs operate by mimicking the inherent actions of GLP-1, a hormone produced by the gut https://saadaepv736346.acidblog.net/70024608/reta-glucagon-like-peptide-1-receptor-agonists